Rare Kidney Stone Consortium Biobank

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT02026388
Status
Recruiting

Conditions

  • APRT Deficiency
  • Cystinuria
  • Dent Disease
  • Primary Hyperoxaluria

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

This study is being done to obtain samples from patients with primary hyperoxaluria, cystinuria, adenine phosphoribosyl transferase (APRT) deficiency, and Dent disease, and from their family members, for use in future research.

Key Dates

Start date
May 31, 2013
Status verified
Jul 2025
Primary completion
Jun 30, 2030
Completion
Jun 30, 2030

Study Design

Enrollment
2,000 participants (estimated)

Arms

  • Arm: Primary Hyperoxaluria
    Diagnosis of Primary Hyperoxaluria, or a family member of someone with this diagnosis.
  • Arm: Dent Disease
    Diagnosis of Dent Disease, or a family member of someone with this diagnosis.
  • Arm: Cystinuria
    Diagnosis of Cystinuria, or a family member of someone with this diagnosis.
  • Arm: APRT deficiency
    Diagnosis of APRT Deficiency, or a family member of someone with this diagnosis.

Primary Outcome Measure

Number of samples stored in tissue bank [ Time Frame: 4 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo ClinicRochesterMinnesota55905
Barbara M Seide
507-255-0387
Leah Knoke
507-293-0467
John C Lieske, M.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

Related Studies